表紙
市場調查報告書

細胞分離的全球市場:2020年∼2024年

Cell Separation Market by End-User and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 626566
出版日期 內容資訊 英文 142 Pages
訂單完成後即時交付
價格
Back to Top
細胞分離的全球市場:2020年∼2024年 Cell Separation Market by End-User and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月19日內容資訊: 英文 142 Pages
簡介

全球細胞分離市場上,研究及臨床應用的細胞分離技術的採用擴大,癌症研究中細胞分離的使用增加,HIV / AIDS的高盛行率等成為成長促進因素,在預測期間內預計將以17%以上的年複合成長率擴大。可是,無一貫性的試劑和其他輔助產品的存在,實驗室人員所面臨的暴露風險,及樣品污染的風險等要素,可能妨礙在預測期間內細胞分離產業的成長。

本報告提供全球細胞分離市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場預測
  • 市場規模及預測(2019年∼2024年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2019年∼2024年)
  • 學術機構及研究所
  • 製藥及生物科技企業
  • 醫院及臨床檢驗室
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 幹細胞相關的研究活動的增加
  • 個體化醫療受到高度的關注
  • 推銷活動焦點

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Akadeum Life Sciences
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Cell Microsystems Inc.
  • Danaher Corp.
  • General Electric Co.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
  • Thermo Fisher Scientific Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR40160

About this market

Technavio's cell separation market analysis considers sales from academic institutions and research laboratories, pharmaceutical and biotechnology companies, and hospitals and clinical testing laboratories end-users. Our study also finds the sales of cell separation in Asia, Europe, North America, and ROW. In 2019, the academic institutions and research laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as demand for cell separation to carry out research studies related to cell enumeration and cell functional assays will play a significant role in the academic institutions and research laboratories segment to maintain its market position. Also, our global cell separation market report looks at factors such as growing adoption of cell separation techniques in research and clinical applications, increasing use of cell separation in cancer research, and high prevalence of HIV/AIDS. However, presence of inconsistent reagents and other ancillary products, exposure risks faced by laboratory personnel, and risk of sample contamination may hamper the growth of the cell separation industry over the forecast period.

Overview

Increasing use of cell separation in cancer research

Cell separation helps the identification and characterization of cancer stem cells. The analysis of single cancer cells by medical practitioners can aid in the early diagnosis of tumors, the monitoring of circulating tumor cells, and the evaluation of intratumor heterogeneity. It can also aid the determination of the need for chemotherapeutic treatments. Also, the incidence of cancer is increasing rapidly, especially amongst women. Cervical and breast cancers are the most common types in the world. The rising incidence of cancer is encouraging further research in the field. Moreover, advances in computer techniques, optics, and lasers introduced a new generation of cell separation techniques which are capable of high speed processing of single cell suspensions. This use of cell separation in cancer research will lead to the expansion of the global cell separation market at a CAGR of over 17% during the forecast period.

Growing focus on personalized medicine

The high number of adverse drug reactions, rising awareness about early diagnosis, and advancements in genetic science are driving the growth of personalized medicines. Genome mapping studies are crucial for the development of personalized medicines, and they could only be achieved if cell separation is performed adequately in studies and research projects. The focus on analyzing DNA synthesis is increasing during cell separation, which can be used for the development of personalized medicines against targets. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global cell separation market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of a few major players, the global cell separation market is highly concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading cell separation manufacturers, that include Akadeum Life Sciences, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Cell Microsystems Inc., Danaher Corp., General Electric Co., Merck KGaA, Miltenyi Biotec BV & Co. KG, pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, and Thermo Fisher Scientific Inc.

Also, the cell separation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Academic institutions and research laboratories -
  • Market size and forecast 2019-2024
  • Pharmaceutical and biotechnology companies -
  • Market size and forecast 2019-2024
  • Hospitals and clinical testing laboratories -
  • Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Increasing number of research activities related to stem cells
  • Growing focus on personalized medicine
  • Focus on promotional activities

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akadeum Life Sciences
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Cell Microsystems Inc.
  • Danaher Corp.
  • General Electric Co.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Vendor offerings
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: End-user - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Academic institutions and research laboratories - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Academic institutions and research laboratories - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Pharmaceutical and biotechnology companies - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Hospitals and clinical testing laboratories - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Hospitals and clinical testing laboratories - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Akadeum Life Sciences - Vendor overview
  • Exhibit 47: Akadeum Life Sciences - Product segments
  • Exhibit 48: Akadeum Life Sciences - Organizational developments
  • Exhibit 49: Akadeum Life Sciences - Key offerings
  • Exhibit 50: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 51: Becton, Dickinson and Co. - Business segments
  • Exhibit 52: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 53: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 54: Becton, Dickinson and Co. - Segment focus
  • Exhibit 55: Becton, Dickinson and Co. - Key offerings
  • Exhibit 56: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 57: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 58: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 59: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 60: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 61: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 62: Cell Microsystems Inc. - Vendor overview
  • Exhibit 63: Cell Microsystems Inc. - Product segments
  • Exhibit 64: Cell Microsystems Inc. - Organizational developments
  • Exhibit 65: Cell Microsystems Inc. - Key offerings
  • Exhibit 66: Danaher Corp. - Vendor overview
  • Exhibit 67: Danaher Corp. - Business segments
  • Exhibit 68: Danaher Corp. - Organizational developments
  • Exhibit 69: Danaher Corp. - Geographic focus
  • Exhibit 70: Danaher Corp. - Segment focus
  • Exhibit 71: Danaher Corp. - Key offerings
  • Exhibit 72: General Electric Co. - Vendor overview
  • Exhibit 73: General Electric Co. - Business segments
  • Exhibit 74: General Electric Co. - Organizational developments
  • Exhibit 75: General Electric Co. - Geographic focus
  • Exhibit 76: General Electric Co. - Segment focus
  • Exhibit 77: General Electric Co. - Key offerings
  • Exhibit 78: Merck KGaA - Vendor overview
  • Exhibit 79: Merck KGaA - Business segments
  • Exhibit 80: Merck KGaA - Organizational developments
  • Exhibit 81: Merck KGaA - Geographic focus
  • Exhibit 82: Merck KGaA - Segment focus
  • Exhibit 83: Merck KGaA - Key offerings
  • Exhibit 84: Miltenyi Biotec BV & Co. KG - Vendor overview
  • Exhibit 85: Miltenyi Biotec BV & Co. KG - Product segments
  • Exhibit 86: Miltenyi Biotec BV & Co. KG - Organizational developments
  • Exhibit 87: Miltenyi Biotec BV & Co. KG - Key offerings
  • Exhibit 88: pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG - Vendor overview
  • Exhibit 89: pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG - Product segments
  • Exhibit 90: pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG - Key offerings
  • Exhibit 91: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 92: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 93: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 94: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 95: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 96: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 97: Validation techniques employed for market sizing
  • Exhibit 98: Definition of market positioning of vendors
Back to Top